日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness

美国传染病学会2025年COVID-19治疗和管理临床实践指南更新:Pemivibart用于暴露前预防,Vilobelimab用于危重症,Abatacept或Infliximab用于重症或危重症。

Bhimraj, Adarsh; Falck-Ytter, Yngve; Baden, Lindsey R; Bedimo, Roger; Cawcutt, Kelly; Cheng, Vincent Chi-Chung; Chew, Kara W; Chiotos, Kathleen; Daar, Eric S; Dzierba, Amy L; Glidden, David V; Hardy, Erica J; Johnson, Steven; Kim, Arthur Y; Li, Jonathan Z; MacBrayne, Christine; Martin, Greg S; Nadig, Nandita; Nakamura, Mari M; Pearson, Jeffrey C; Riley, Laura; Shafer, Robert W; Shoham, Shmuel; Shumaker, Amy Hirsch; Tebas, Pablo; Tien, Phyllis C; Loveless, Jennifer; Morgan, Rebecca L; Gandhi, Rajesh T

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab

美国传染病学会2025年COVID-19治疗和管理临床实践指南更新:维洛贝利单抗

Nadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L; Kim, Arthur Y; Martin, Greg S; Pearson, Jeffrey C; Shumaker, Amy Hirsch; Baden, Lindsey R; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W; Daar, Eric S; Glidden, David V; Hardy, Erica J; Johnson, Steven; Li, Jonathan Z; MacBrayne, Christine; Nakamura, Mari M; Riley, Laura; Shafer, Robert W; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L; Gandhi, Rajesh T

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab

美国传染病学会2025年COVID-19治疗和管理临床实践指南更新:英夫利昔单抗

Nadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L; Kim, Arthur Y; Martin, Greg S; Pearson, Jeffrey C; Shumaker, Amy Hirsch; Baden, Lindsey R; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W; Daar, Eric S; Glidden, David V; Hardy, Erica J; Johnson, Steven; Li, Jonathan Z; MacBrayne, Christine; Nakamura, Mari M; Riley, Laura; Shafer, Robert W; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L; Gandhi, Rajesh T

Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study

ACTIV-2 研究中急性 COVID 期间不同人群的病毒脱落和症状严重程度

Kung, Evelyn; Deo, Rinki; Choudhary, Manish C; Chew, Kara W; Evering, Teresa H; Ignacio, Rachel Bender; Jagannathan, Prasanna; Flynn, James P; Regan, James; Moser, Carlee; Giganti, Mark J; Hughes, Michael D; Ritz, Justin; Javan, Arzhang Cyrus; Greninger, Alexander L; Singh, Upinder; Fischer, William; Daar, Eric S; Wohl, David A; Eron, Joseph J; Currier, Judith S; Coombs, Robert W; Smith, Davey M; Li, Jonathan Z

Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial

恩西替利韦治疗非住院成人 COVID-19 患者:SCORPIO-HR 3 期随机、双盲、安慰剂对照试验结果

Luetkemeyer, Anne F; Chew, Kara W; Lacey, Stuart; Hughes, Michael D; Harrison, Linda J; Daar, Eric S; Eron, Joseph; Fletcher, Courtney V; Greninger, Alexander L; Hessinger, Diane; Li, Jonathan Z; Mailhot, David; Wohl, David; Chayakulkeeree, Methee; Mendoza, Jose Luis Accini; Elistratova, Polina; Makinde, Oluwaseun; Morgan, Gareth; Portsmouth, Simon; Uehara, Takeki; Smith, Davey; Currier, Judith S

Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.

在随机安慰剂对照试验中,使用抗严重急性呼吸综合征冠状病毒 2 单克隆抗体疗法后出现病毒和症状反弹

Chew Kara W, McGinley Brooke, Moser Carlee, Li Jonathan Z, Evering Teresa H, Ritz Justin, Javan Arzhang Cyrus, Margolis David, Wohl David A, Hughes Michael D, Daar Eric S, Currier Judith S, Eron Joseph J, Smith Davey M

Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies

ACTIV-2 研究中,Tixagevimab/cilgavimab 或安慰剂治疗 COVID-19 的安全性、药代动力学以及中和抗体和抗药抗体

Bender Ignacio, Rachel A; Chew, Kara W; Moser, Carlee; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Giganti, Mark J; Ritz, Justin; Gibbs, Michael; Kouekam, Hervé Tchouakam; Esser, Mark T; Daar, Eric S; Choudhary, Manish; Deo, Rinki; Fletcher, Courtney V; Li, Jonathan Z; Hughes, Michael D; Smith, Davey; Wohl, David Alain

Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 Weeks

使用多替拉韦和/或马拉维罗克强化抗逆转录病毒疗法12周后,并未影响HIV-1细胞相关的DNA、RNA和2-LTR环。

Reed, Jonathan C; Hall, Luke; McKhann, Ashley; Kwak, Ginger; Goecker, Erin A; Coombs, Robert W; Chen, Huichao; Roa, Jhoanna; Vecchio, Alyssa; Daar, Eric S; Hunt, Peter W; Marra, Christina M; Campbell, Thomas B; Ma, Qing; Swaminathan, Shobha; Macatangay, Bernard J C; Morse, Gene D; Miller, Thomas; Rusin, David; Ha, Belinda; Alston-Smith, Beverly; Paul, Robert; Letendre, Scott L; Spudich, Serena S; Greninger, Alexander L

Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

通过肌内或静脉注射抗病毒单克隆抗体疗法快速清除可培养的SARS-CoV-2病毒

Deo, Rinki; Choudhary, Manish C; Glover, Owen T; Ignacio, Rachel Bender; Boucau, Julie; Chew, Kara W; Moser, Carlee; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Giganti, Mark J; Aga, Evgenia; Gibbs, Michael; Cohen, Taylor; Streicher, Katie; Soboleva, Karina; Fletcher, Courtney V; Daar, Eric S; Greninger, Alexander L; Coombs, Robert W; Fischer, William; Hughes, Michael D; Smith, Davey; Wohl, David Alain; Barczak, Amy K; Li, Jonathan Z

Association of Intracellular Microstructural and Neuropsychological Changes in HIV: A Pilot Validation of Trace Diffusion-Weighted Magnetic Resonance Spectroscopic Imaging Using Radial Trajectories

HIV感染者细胞内微观结构与神经心理变化的关联:基于径向轨迹的示踪扩散加权磁共振波谱成像的初步验证

Joy, Ajin; Saucedo, Andres; Wright, Matthew J; Vallabhu, Pranathi; Gupta, Neha; Sayre, James; Chien, Aichi; Emir, Uzay; Macey, Paul M; Daar, Eric S; Thomas, M Albert